Dog Osteosarcoma Palliative Care and Quality of Life

Osteosarcoma is the most common primary bone tumour in dogs, causing severe, progressive pain that is often underestimated by owners. Effective palliative analgesia and amputation can significantly extend comfortable life even when cure is not possible.

Key Facts

Osteosarcoma accounts for approximately 85 per cent of all primary bone tumours in dogs
Large and giant breeds — particularly Rottweilers, Great Danes, and Irish Wolfhounds — are disproportionately affected
The appendicular skeleton, especially the distal radius and proximal humerus, is involved in 75 per cent of cases
Median survival with amputation and adjuvant chemotherapy is around 10 to 12 months, versus 1 to 4 months with palliative care only
Bisphosphonates such as pamidronate reduce bone pain and may slow tumour progression in some dogs

Welfare Considerations

Osteosarcoma pain is severe and continuous: dogs often mask it until catastrophic pathological fracture occurs. Welfare-centred management begins at first diagnosis with multimodal analgesia — combining NSAIDs, gabapentin, and bisphosphonates — to maintain comfortable function. Owners should be given explicit guidance on mobility scoring and appetite assessment so that quality of life is monitored daily. Amputation is not cruel; most dogs adapt rapidly and maintain excellent quality of life. Advance end-of-life planning reduces the risk of a traumatic final presentation.

What You Can Do

Seek oncology referral promptly if bone tumour is suspected — early pain management improves quality of life
Ask your vet about multimodal analgesia protocols specific to bone pain management
Monitor mobility, appetite, and engagement daily using a structured quality-of-life scoring sheet
Discuss amputation openly with your vet — most dogs adapt quickly and experience rapid pain relief
Plan ahead for end-of-life decisions to avoid emergency presentations in unmanaged pain